Unichem Laboratories Statistics
Total Valuation
Unichem Laboratories has a market cap or net worth of INR 49.91 billion. The enterprise value is 50.86 billion.
Market Cap | 49.91B |
Enterprise Value | 50.86B |
Important Dates
The next estimated earnings date is Monday, October 21, 2024.
Earnings Date | Oct 21, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Unichem Laboratories has 70.41 million shares outstanding. The number of shares has decreased by -2.63% in one year.
Shares Outstanding | 70.41M |
Shares Change (YoY) | -2.63% |
Shares Change (QoQ) | +0.37% |
Owned by Insiders (%) | 18.59% |
Owned by Institutions (%) | 14.21% |
Float | 19.42M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.85 |
PB Ratio | 2.11 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -84.00 |
EV / Sales | 2.94 |
EV / EBITDA | 43.83 |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.10 |
Debt / EBITDA | 2.13 |
Debt / FCF | n/a |
Interest Coverage | 0.14 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 0.07% |
Revenue Per Employee | 6.01M |
Profits Per Employee | -210,609 |
Employee Count | 2,875 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +69.66% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +69.66% |
50-Day Moving Average | 606.47 |
200-Day Moving Average | 541.45 |
Relative Strength Index (RSI) | 68.32 |
Average Volume (20 Days) | 6,631 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Unichem Laboratories had revenue of INR 17.28 billion and -605.50 million in losses. Loss per share was -8.71.
Revenue | 17.28B |
Gross Profit | 10.13B |
Operating Income | 29.32M |
Pretax Income | -487.84M |
Net Income | -605.50M |
EBITDA | 1.10B |
EBIT | 29.32M |
Loss Per Share | -8.71 |
Balance Sheet
The company has 1.52 billion in cash and 2.48 billion in debt, giving a net cash position of -952.63 million or -13.53 per share.
Cash & Cash Equivalents | 1.52B |
Total Debt | 2.48B |
Net Cash | -952.63M |
Net Cash Per Share | -13.53 |
Equity (Book Value) | 23.62B |
Book Value Per Share | 335.54 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 58.63%, with operating and profit margins of 0.17% and -3.50%.
Gross Margin | 58.63% |
Operating Margin | 0.17% |
Pretax Margin | -2.82% |
Profit Margin | -3.50% |
EBITDA Margin | 6.38% |
EBIT Margin | 0.17% |
FCF Margin | n/a |
Dividends & Yields
Unichem Laboratories does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 2.63% |
Shareholder Yield | 2.63% |
Earnings Yield | -1.23% |
FCF Yield | n/a |
Stock Splits
The last stock split was on October 21, 2010. It was a forward split with a ratio of 2.5.
Last Split Date | Oct 21, 2010 |
Split Type | Forward |
Split Ratio | 2.5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |